Approval · Notice of Compliance 4454 · 1996
IBUPROFEN: Notice of Compliance 4454
Issued March 5, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4454
- Date
- March 5, 1996
- Company
- Stanley Pharmaceuticals Ltd.North Vancouver, BC, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Anti-inflammatory, analgesic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IBUPROFEN | 02213389 | Cancelled Post Market |
Medicinal ingredients
- IBUPROFEN 200 MG per TAB